Notice2021-18505
National Center for Advancing Translational Sciences; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 27, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 164 (Friday, August 27, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Page 48230]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-18505]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the cooperative agreement applications, the disclosure
of which would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; RFA-TR-21-009: Screening for
Conditions by Electronic Nose Technology (SCENT).
Date: September 28, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Room 1078,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review
Officer, Office of Grants Management and Scientific Review, National
Center for Advancing Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room 1078, Bethesda, MD 20892,
301-894-7319, <a href="/cdn-cgi/l/email-protection#fa91929b9488c8ba998988d4949392d49d958c"><span class="__cf_email__" data-cfemail="92f9faf3fce0a0d2f1e1e0bcfcfbfabcf5fde4">[email protected]</span></a>.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; National Center for Advancing
Translational Sciences Special Emphasis Panel.
Date: September 30, 2021
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Room 1078,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alumit Ishai, Ph.D., Scientific Review Officer,
Office of Grants Management and Scientific Review, National Center
for Advancing Translational Sciences, National Institutes of Health,
6701 Democracy Boulevard, Suite 1000, Bethesda, MD 20892, 301-827-
5819, <a href="/cdn-cgi/l/email-protection#95f4f9e0f8fce1bbfce6fdf4fcd5fbfcfdbbf2fae3"><span class="__cf_email__" data-cfemail="60010c150d09144e0913080109200e09084e070f16">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: August 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18505 Filed 8-26-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 27, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.